Advertisement

Topics

Inotrem S.A. Company Profile

04:09 EDT 22nd September 2018 | BioPortfolio

Inotrem is a biotechnology company specialized in the control of excessive immune response that occurs in acute inflammatory syndromes in the critical care setting. It has developed a new concept of immunomodulation to control abnormal immune response to tissue injuries, using a personalized medicine approach. The Company has been founded in 2013 in Nancy by Dr. Jean-Jacques Garaud, a former head of research and early development at the Roche Group, Prof. Sébastien Gibot and Dr. Marc Derive.


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Inotrem S.A.

Inotrem is a biotechnology company specialized in the control of excessive immune response that occurs in acute inflammatory syndromes in the critical care setting. It has develop...

Inotrem

More Information about "Inotrem S.A." on BioPortfolio

We have published hundreds of Inotrem S.A. news stories on BioPortfolio along with dozens of Inotrem S.A. Clinical Trials and PubMed Articles about Inotrem S.A. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Inotrem S.A. Companies in our database. You can also find out about relevant Inotrem S.A. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record